Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lumos Pharma Inc.

    NASDAQ: LUMO · Real-Time Price · USD
    4.34
    0.00 (0.00%)
    At close: Dec 11, 2024, 10:00 PM

    Lumos Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.05M 1.52M 230K
    Cost of Revenue
    		 n/a 49K n/a
    Gross Profit
    		 2.05M 1.47M 230K
    Operating Income
    		 -36.61M -32.04M -31.35M
    Interest Income
    		 1.87M 874K 12K
    Pretax Income
    		 -34.06M -31.07M -31.07M
    Net Income
    		 -34.03M -31.06M -30.43M
    Selling & General & Admin
    		 16.57M 15.71M 15.33M
    Research & Development
    		 22.1M 17.86M 16.25M
    Other Expenses
    		 n/a 91K 269K
    Operating Expenses
    		 38.66M 33.56M 31.58M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 38.66M 33.56M 31.58M
    Income Tax Expense
    		 -29K -13K -636K
    Shares Outstanding (Basic)
    		 8.15M 8.37M 8.33M
    Shares Outstanding (Diluted)
    		 8.15M 8.37M 8.33M
    EPS (Basic)
    		 -4.18 -3.71 -3.65
    EPS (Diluted)
    		 -4.18 -3.71 -3.65
    EBITDA
    		 -36.57M -31.99M -31.13M
    EBIT
    		 -36.61M -32.04M -31.35M
    Depreciation & Amortization
    		 44K 49K 273K

    Add to Watchlist